Statistics for Roivant Sciences Ltd. (id:6401 ROIV)

Valuation metrics

Market cap

8.61B

Enterprise value

3.89B

Trailing P/E (ttm)

2.03

Forward P/E

-9.78

PEG ratio

-9.78

Price/Sales (ttm)

54.38

Price/Book (mrq)

1.57

Enterprise Value/Revenue

24.60

Enterprise Value/EBITDA

-3.83

Overview

Shares outstanding

739.52M

Float

363.13M

Shares short

50.19M

% Held by insiders

0.29%

% Held by institutions

0.79%

Average volume (10 days)

3.57M

Average volume (90 days)

Price summary

52-Week low

8.61

52-Week high

13.06

52-Week change

21.67%

Beta

1.24

50-Day moving average

11.78

200-Day moving average

11.16

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

March 31th, 2024

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

2.99K%

Operating margin

-402.44%

Operational effectiveness

Return on assets

-15.03%

Return on equity

127.71%

Income statement

Revenue (ttm)

0.20

Revenue per share (ttm)

0.20

Quarterly revenue growth (yoy)

Gross profit (ttm)

109.24M

EBITDA

-1,016,824,000.00

Net income to common (ttm)

4.74B

Diluted EPS (ttm)

5.73

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

5.68B

Total cash per share (mrq)

7.68

Total debt (mrq)

379.06M

Total Debt/Equity (mrq)

6.43

Current ratio (mrq)

2.79K%

Book value per share (mrq)

7.40

Cash flow

Cash flow statement

-708,164,992.00

Levered free cash flow (LFCF)

-645,150,656.00